公司概述
FMC Corporation operates as an agricultural sciences enterprise dedicated to the development, marketing, and sale of crop protection chemicals across Latin America, North America, Europe, the Middle East, Africa, and Asia. The company's product portfolio specifically includes insecticides, herbicides, and fungicides, alongside bio-based solutions, serving the global agricultural inputs industry within the broader basic materials sector. This sector classification indicates that the company's performance is intrinsically linked to global commodity cycles and agricultural demand rather than consumer discretionary spending patterns. The organization employs approximately 5,500 individuals and maintains a total market capitalization of $2.15 billion, reflecting a mid-cap valuation that suggests a significant but not dominant market position. With annual revenue reaching $3.47 billion, these figures demonstrate that FMC generates substantial top-line volume, yet the specific market cap relative to revenue implies a valuation that does not command a significant premium over its sales base, positioning it as a specialized player rather than a broad-scale monopoly in its respective industries.
财务健康
The company reported total revenue of $3.47 billion over the trailing twelve months, while net income stood at -$2.20 billion, creating a stark disparity that reveals a highly volatile cost structure or significant non-operating losses impacting the bottom line. Despite the negative net income, EBITDA remains positive at $413.80 million, indicating that core operational cash generation persists even when accounting for interest and taxes significantly erodes shareholder value. Free cash flow for the period was $94.78 million, which provides a measure of financial flexibility to fund operations and debt servicing despite the reported accounting losses. The gross margin stands at 33.8%, suggesting that the cost of goods sold consumes roughly two-thirds of revenue before operating expenses are considered, while the operating margin of 9.5% indicates that administrative and sales costs further compress profitability before tax effects. However, the profit margin is negative at -64.6%, a figure that directly correlates with the massive negative net income and highlights the severe impact of interest or other expenses on the final bottom line. The balance sheet shows cash reserves of $584.50 million against total debt of $4.20 billion, resulting in a debt-to-equity ratio of 200.05%, which characterizes the company as highly leveraged with substantial fixed obligations relative to its equity base. Liquidity is assessed via a current ratio of 1.32, indicating that current assets exceed current liabilities by a moderate margin, suggesting the company can meet short-term obligations but may face pressure if cash flows do not improve. Return on Equity is recorded at -66.6% and return on assets at 1.4%, metrics that collectively reveal that management effectiveness has been compromised by the current loss position, as equity holders are facing a substantial dilution of value while asset utilization generates minimal positive returns.
估值评估
Valuation multiples show a trailing P/E ratio of N/A due to the current lack of net income, whereas the forward P/E is 7.67, implying that the market expects earnings to recover and stabilize in the near future to justify a low multiple. The price-to-book ratio is 1.04, which suggests that the market is pricing the company's equity at nearly its book value, indicating no significant premium or discount relative to the net asset position. Alternative valuation metrics include a price-to-sales ratio of 0.62 and an EV/EBITDA of 14.00, figures that suggest the company is valued conservatively based on sales revenue and enterprise value relative to earnings before interest, taxes, depreciation, and amortization. The stock's 52-week trading range spans from a low of $12.17 to a high of $44.78, meaning the current price sits significantly below the 52-week high, reflecting a substantial correction or consolidation phase over the past year. The beta value is 0.52, indicating that the stock's price volatility is less than half that of the broader market, suggesting it behaves as a defensive or low-volatility asset within the basic materials sector.
Growth & Income
Revenue growth year-over-year is negative at -11.5%, while earnings growth is N/A due to the current loss position, implying that the company is currently contracting in terms of top-line sales rather than expanding its revenue base. The company maintains a dividend yield of 1.9% with a payout ratio of 223.1%, a metric that is mathematically unsustainable given the negative net income and indicates that dividends are being funded from cash reserves rather than earnings. This high payout ratio coupled with negative earnings suggests that the company is paying out more than its current profitability supports, relying heavily on liquidity rather than operational profits to sustain shareholder distributions. The overall growth and income profile presents a mixed picture where declining revenue and negative earnings contrast with a high dividend yield, creating a scenario where income returns exist but are not supported by fundamental earnings growth or profitability.